View in EDS

Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study.

Saved in:
Bibliographic Details
Title: Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study.
Authors: Connor MJ; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. Electronic address: m.connor@imperial.ac.uk., Genie M; Health Economics Research Unit (HERU), Institute of Applied Health Science, School of Medicine, Medical Science and Nutrition, University of Aberdeen, Aberdeen, UK; Newcastle Business School, University of Newcastle, Newcastle, NSW, Australia; Department of Population Health Sciences, Duke University, Durham, USA., Dudderidge T; Urology, University Hospital Southampton, Southampton, UK., Wu H; Health Economics Research Unit (HERU), Institute of Applied Health Science, School of Medicine, Medical Science and Nutrition, University of Aberdeen, Aberdeen, UK., Sukumar J; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer Imperial College London, London, UK; Imperial College Clinical Trials Unit, Imperial College London, London, UK., Beresford M; Department of Oncology, Royal United Hospitals Bath, Bath, UK., Bianchini D; Department of Oncology and Urology, Medway Maritime Hospital, Kent, UK., Goh C; Department of Oncology, East Surrey Hospital, Redhill, UK., Horan G; Department of Oncology, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust & The Cancer Centre, Addenbrooke's Hospital, Cambridge, UK., Innominato P; Department of Oncology, Betsi Cadwaladr University Health Board, Bangor, UK., Khoo V; Department of Oncology, The Royal Marsden Hospital, London, UK., Klimowska-Nassar N; Imperial College Clinical Trials Unit, Imperial College London, London, UK., Madaan S; Department of Urology, Dartford and Gravesham NHS Trust, Kent, UK., Mangar S; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK., McCracken S; Department of Urology, Sunderland Royal Hospital, Sunderland, UK., Ostler P; Department of Oncology, Luton and Dunstable University Hospital, Luton, UK., Paisey S; Department of Oncology, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK., Robinson A; Department of Oncology, Royal Sussex County Hospital, Brighton, UK., Rai B; Department of Urology, Newcastle Freeman Hospital, Newcastle, UK., Sarwar N; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK., Srihari N; Department of Oncology, Royal Shrewsbury Hospital, Shrewsbury, UK., Jayaprakash KT; Department of Oncology, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust & The Cancer Centre, Addenbrooke's Hospital, Cambridge, UK., Varughese M; Department of Oncology, Royal Devon and Exeter NHS Foundation Trust, Oncology, Exeter, UK., Winkler M; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Department of Urology, West Middlesex University Hospital, London, UK., Ahmed HU; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Watson V; Health Economics Research Unit (HERU), Institute of Applied Health Science, School of Medicine, Medical Science and Nutrition, University of Aberdeen, Aberdeen, UK.
Corporate Authors: IP5-MATTER Trial Investigators
Source: European urology oncology [Eur Urol Oncol] 2025 Jun; Vol. 8 (3), pp. 663-673. Date of Electronic Publication: 2024 Jul 06.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38972831
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Connor+MJ%22">Connor MJ</searchLink>; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. Electronic address: m.connor@imperial.ac.uk.<br /><searchLink fieldCode="AU" term="%22Genie+M%22">Genie M</searchLink>; Health Economics Research Unit (HERU), Institute of Applied Health Science, School of Medicine, Medical Science and Nutrition, University of Aberdeen, Aberdeen, UK; Newcastle Business School, University of Newcastle, Newcastle, NSW, Australia; Department of Population Health Sciences, Duke University, Durham, USA.<br /><searchLink fieldCode="AU" term="%22Dudderidge+T%22">Dudderidge T</searchLink>; Urology, University Hospital Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Wu+H%22">Wu H</searchLink>; Health Economics Research Unit (HERU), Institute of Applied Health Science, School of Medicine, Medical Science and Nutrition, University of Aberdeen, Aberdeen, UK.<br /><searchLink fieldCode="AU" term="%22Sukumar+J%22">Sukumar J</searchLink>; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer Imperial College London, London, UK; Imperial College Clinical Trials Unit, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Beresford+M%22">Beresford M</searchLink>; Department of Oncology, Royal United Hospitals Bath, Bath, UK.<br /><searchLink fieldCode="AU" term="%22Bianchini+D%22">Bianchini D</searchLink>; Department of Oncology and Urology, Medway Maritime Hospital, Kent, UK.<br /><searchLink fieldCode="AU" term="%22Goh+C%22">Goh C</searchLink>; Department of Oncology, East Surrey Hospital, Redhill, UK.<br /><searchLink fieldCode="AU" term="%22Horan+G%22">Horan G</searchLink>; Department of Oncology, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust & The Cancer Centre, Addenbrooke's Hospital, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Innominato+P%22">Innominato P</searchLink>; Department of Oncology, Betsi Cadwaladr University Health Board, Bangor, UK.<br /><searchLink fieldCode="AU" term="%22Khoo+V%22">Khoo V</searchLink>; Department of Oncology, The Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Klimowska-Nassar+N%22">Klimowska-Nassar N</searchLink>; Imperial College Clinical Trials Unit, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Madaan+S%22">Madaan S</searchLink>; Department of Urology, Dartford and Gravesham NHS Trust, Kent, UK.<br /><searchLink fieldCode="AU" term="%22Mangar+S%22">Mangar S</searchLink>; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22McCracken+S%22">McCracken S</searchLink>; Department of Urology, Sunderland Royal Hospital, Sunderland, UK.<br /><searchLink fieldCode="AU" term="%22Ostler+P%22">Ostler P</searchLink>; Department of Oncology, Luton and Dunstable University Hospital, Luton, UK.<br /><searchLink fieldCode="AU" term="%22Paisey+S%22">Paisey S</searchLink>; Department of Oncology, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.<br /><searchLink fieldCode="AU" term="%22Robinson+A%22">Robinson A</searchLink>; Department of Oncology, Royal Sussex County Hospital, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Rai+B%22">Rai B</searchLink>; Department of Urology, Newcastle Freeman Hospital, Newcastle, UK.<br /><searchLink fieldCode="AU" term="%22Sarwar+N%22">Sarwar N</searchLink>; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Srihari+N%22">Srihari N</searchLink>; Department of Oncology, Royal Shrewsbury Hospital, Shrewsbury, UK.<br /><searchLink fieldCode="AU" term="%22Jayaprakash+KT%22">Jayaprakash KT</searchLink>; Department of Oncology, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust & The Cancer Centre, Addenbrooke's Hospital, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Varughese+M%22">Varughese M</searchLink>; Department of Oncology, Royal Devon and Exeter NHS Foundation Trust, Oncology, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22Winkler+M%22">Winkler M</searchLink>; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Department of Urology, West Middlesex University Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Ahmed+HU%22">Ahmed HU</searchLink>; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Watson+V%22">Watson V</searchLink>; Health Economics Research Unit (HERU), Institute of Applied Health Science, School of Medicine, Medical Science and Nutrition, University of Aberdeen, Aberdeen, UK.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22IP5-MATTER+Trial+Investigators%22">IP5-MATTER Trial Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101724904%22">European urology oncology</searchLink> [Eur Urol Oncol] 2025 Jun; Vol. 8 (3), pp. 663-673. <i>Date of Electronic Publication: </i>2024 Jul 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101724904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2588-9311 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225889311%22">25889311 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38972831
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.euo.2024.06.010
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 663
    Titles:
      – TitleFull: Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Connor MJ
      – PersonEntity:
          Name:
            NameFull: Genie M
      – PersonEntity:
          Name:
            NameFull: Dudderidge T
      – PersonEntity:
          Name:
            NameFull: Wu H
      – PersonEntity:
          Name:
            NameFull: Sukumar J
      – PersonEntity:
          Name:
            NameFull: Beresford M
      – PersonEntity:
          Name:
            NameFull: Bianchini D
      – PersonEntity:
          Name:
            NameFull: Goh C
      – PersonEntity:
          Name:
            NameFull: Horan G
      – PersonEntity:
          Name:
            NameFull: Innominato P
      – PersonEntity:
          Name:
            NameFull: Khoo V
      – PersonEntity:
          Name:
            NameFull: Klimowska-Nassar N
      – PersonEntity:
          Name:
            NameFull: Madaan S
      – PersonEntity:
          Name:
            NameFull: Mangar S
      – PersonEntity:
          Name:
            NameFull: McCracken S
      – PersonEntity:
          Name:
            NameFull: Ostler P
      – PersonEntity:
          Name:
            NameFull: Paisey S
      – PersonEntity:
          Name:
            NameFull: Robinson A
      – PersonEntity:
          Name:
            NameFull: Rai B
      – PersonEntity:
          Name:
            NameFull: Sarwar N
      – PersonEntity:
          Name:
            NameFull: Srihari N
      – PersonEntity:
          Name:
            NameFull: Jayaprakash KT
      – PersonEntity:
          Name:
            NameFull: Varughese M
      – PersonEntity:
          Name:
            NameFull: Winkler M
      – PersonEntity:
          Name:
            NameFull: Ahmed HU
      – PersonEntity:
          Name:
            NameFull: Watson V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2588-9311
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: European urology oncology
              Type: main
ResultId 1